Lainie Ross to Infant, Newborn
This is a "connection" page, showing publications Lainie Ross has written about Infant, Newborn.
Connection Strength
3.418
-
The moral status of the newborn and its implications for medical decision making. Theor Med Bioeth. 2007; 28(5):349-55.
Score: 0.160
-
Newborn Sequencing: The Promise and Perils. Annu Rev Genomics Hum Genet. 2025 Aug; 26(1):401-423.
Score: 0.145
-
Achieving Live Birth is Not an Endpoint but a Steppingstone. Am J Bioeth. 2024 10; 24(10):115-117.
Score: 0.137
-
Newborn Screening for Neurodevelopmental Disorders May Exacerbate Health Disparities. Pediatrics. 2023 10 01; 152(4).
Score: 0.128
-
Expounding on Shared Decision-Making in Pediatrics. J Pediatr. 2022 12; 251:3-5.
Score: 0.119
-
Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J. 2002 Sep; 12(3):225-44.
Score: 0.119
-
The Harms of Carrier Status Identification: A Cautionary Warning Against Newborn Sequencing. J Pediatr. 2020 09; 224:22-23.
Score: 0.101
-
Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq. Pediatrics. 2019 12; 144(6).
Score: 0.098
-
Spinal Muscular Atrophy: Past, Present, and Future. Neoreviews. 2019 08; 20(8):e437-e451.
Score: 0.096
-
50 Years Ago in The Journal of Pediatrics: Maternal Phenylketonuria: Implications for Growth and Development. J Pediatr. 2018 10; 201:121.
Score: 0.091
-
The Complexities of Ascertaining Public Preferences for Newborn Screening Policies. J Pediatr. 2018 10; 201:8-9.
Score: 0.089
-
50 Years Ago in The Journal of Pediatrics: Variability in the Manifestations of Phenylketonuria/Transient Hyperphenylalaninemia. J Pediatr. 2018 04; 195:65.
Score: 0.087
-
Threading the Needle for the Tiniest Babies. J Pediatr. 2017 11; 190:8-9.
Score: 0.085
-
A Historical and Current Review of Newborn Screening for Neuromuscular Disorders From Around the World: Lessons for the United States. Pediatr Neurol. 2017 Dec; 77:12-22.
Score: 0.084
-
50 Years Ago in TheJournal ofPediatrics: Legislation and Advances in Medical Knowledge-Acceleration or Inhibition? J Pediatr. 2016 08; 175:53.
Score: 0.078
-
50 Years Ago in The Journal of Pediatrics: Phenylketonuria in a Negro Infant. J Pediatr. 2015 Aug; 167(2):304.
Score: 0.073
-
Ethical and policy issues in newborn screening of children for neurologic and developmental disorders. Pediatr Clin North Am. 2015 Jun; 62(3):787-98.
Score: 0.071
-
Universal state newborn screening programs can reduce health disparities. JAMA Pediatr. 2015 Jan; 169(1):7-8.
Score: 0.070
-
Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med. 2013 Mar; 15(3):234-45.
Score: 0.061
-
A pilot study to evaluate awareness of and attitudes about prenatal and neonatal genetic testing in postpartum African American women. J Natl Med Assoc. 2013; 105(1):85-91.
Score: 0.061
-
50 years ago in the Journal of Pediatrics: mass screening for phenylketonuria. J Pediatr. 2012 Sep; 161(3):433.
Score: 0.059
-
50 years ago in the Journal of Pediatrics: comparison of serum phenylalanine levels with growth in Guthrie's inhibition assay in newborn infants. J Pediatr. 2012 Sep; 161(3):530.
Score: 0.059
-
Parents: critical stakeholders in expanding newborn screening. J Pediatr. 2012 Sep; 161(3):385-9.
Score: 0.059
-
Newborn screening for lysosomal storage diseases: an ethical and policy analysis. J Inherit Metab Dis. 2012 Jul; 35(4):627-34.
Score: 0.057
-
Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test. Pediatrics. 2011 Feb; 127(2):276-83.
Score: 0.053
-
Mandatory versus voluntary consent for newborn screening? Kennedy Inst Ethics J. 2010 Dec; 20(4):299-328.
Score: 0.053
-
Maternal attitudes about sickle cell trait identification in themselves and their infants. J Natl Med Assoc. 2010 Nov; 102(11):1065-72.
Score: 0.052
-
Are we ready to expand donation after cardiac death to the newborn population? J Pediatr. 2011 Jan; 158(1):6-8.
Score: 0.052
-
A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis. Am J Perinatol. 2011 Mar; 28(3):169-76.
Score: 0.052
-
An ethical and policy analysis of elective transplantation for metabolic conditions diagnosed by newborn screening. J Pediatr. 2010 Jan; 156(1):139-44.
Score: 0.049
-
Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis. Am J Med Genet A. 2009 Nov; 149A(11):2424-9.
Score: 0.049
-
Clinical and ethical considerations in managing carrier detection. Am J Public Health. 2009 Aug; 99(8):1348-9.
Score: 0.048
-
Fragile X screening: attitudes of genetic health professionals. Am J Med Genet A. 2009 Feb 15; 149A(4):626-32.
Score: 0.046
-
Pediatricians' attitudes about screening newborns for infectious diseases. Matern Child Health J. 2010 Mar; 14(2):174-83.
Score: 0.046
-
Newborn screening for cystic fibrosis: a lesson in public health disparities. J Pediatr. 2008 Sep; 153(3):308-13.
Score: 0.045
-
Ethical and policy issues in pediatric genetics. Am J Med Genet C Semin Med Genet. 2008 Feb 15; 148C(1):1-7.
Score: 0.043
-
Against newborn screening for type 1 diabetes. Arch Pediatr Adolesc Med. 2007 Jun; 161(6):616-7; author reply 617-8.
Score: 0.041
-
Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy. Am J Med Genet A. 2006 Nov 01; 140(21):2305-11.
Score: 0.040
-
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children. Am J Med Genet A. 2006 Nov 01; 140(21):2312-9.
Score: 0.040
-
Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs. Pediatrics. 2006 May; 117(5):1477-85.
Score: 0.038
-
Newborn screening technology: proceed with caution. Pediatrics. 2006 May; 117(5):1793-9.
Score: 0.038
-
Screening for conditions that do not meet the Wilson and Jungner criteria: the case of Duchenne muscular dystrophy. Am J Med Genet A. 2006 Apr 15; 140(8):914-22.
Score: 0.038
-
Parent Recollections of Newborn Screening With an Emphasis on Cystic Fibrosis. Acad Pediatr. 2026 Jul; 26(5):103303.
Score: 0.038
-
Ethical considerations related to pregnancy in transplant recipients. N Engl J Med. 2006 Mar 23; 354(12):1313-6.
Score: 0.038
-
Pediatricians' attitudes toward expanding newborn screening. Pediatrics. 2005 Oct; 116(4):e476-84.
Score: 0.037
-
The Newborn Screening Experience of Caregivers of Children With Cystic Fibrosis in the United States: A Cross-Sectional Survey. Pediatr Pulmonol. 2025 May; 60(5):e71110.
Score: 0.036
-
Should children and adolescents undergo genetic testing? Pediatr Ann. 2004 Nov; 33(11):762-9.
Score: 0.035
-
Incorporating newborn screening into prenatal care. Am J Obstet Gynecol. 2004 Apr; 190(4):876-7.
Score: 0.033
-
Children in medical research: balancing protection and access--has the pendulum swung too far? Perspect Biol Med. 2004; 47(4):519-36.
Score: 0.033
-
Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet A. 2003 Jul 15; 120A(2):209-14.
Score: 0.032
-
Lethal language, lethal decisions. Hastings Cent Rep. 2003 Mar-Apr; 33(2):37-41.
Score: 0.031
-
Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med. 2003 Jan; 157(1):89-95.
Score: 0.030
-
An Ethical Analysis of Newborn Congenital Cytomegalovirus Screening. Pediatrics. 2022 06 01; 149(6).
Score: 0.029
-
Advantages and disadvantages of neonatal circumcision. JAMA. 1997 Jul 16; 278(3):201-2; author reply 203.
Score: 0.021
-
The OHRP and SUPPORT. N Engl J Med. 2013 Jun 20; 368(25):e36.
Score: 0.016